Folium Isatidis suppresses PCV2 replication and alleviates PCV2-induced lung injury by modulating the PI3K/AKT signaling pathway and TNF-α activity
International Immunopharmacology · 2026-06 · 179 · 116641
DOI: 10.1016/j.intimp.2026.116641 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-06. Verfasst von Lei Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Northwest A&F University, Yangling, China. Hauptthemen laut MEDLINE: Circovirus, Circoviridae Infections, Drugs, Chinese Herbal, Antiviral Agents. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Chinese Universities Scientific Fund, National Natural Science Foundation of China, shaanxi sheng kexue jishu ting.
Abstract (Originalsprache)
BACKGROUND Folium Isatidis (Da Qing Ye), a traditional Chinese medicine, exhibits broad-spectrum antiviral and immunomodulatory properties and has been widely used in treating respiratory diseases. Porcine circovirus type 2 (PCV2), a widespread swine virus, causes respiratory disease complex in piglets and leads to substantial economic losses in the global swine industry. This study aimed to evaluate the anti-PCV2 activity of Folium Isatidis. MATERIALS AND METHODS The anti-PCV2 activity of Folium Isatidis was first validated through both in vivo and in vitro experiments. Potential targets of Folium Isatidis were identified using TCMSP, BATMAN-TCM, and SwissTargetPrediction databases, and intersected with PCV2-related targets. Mechanism exploration involved PPI network analysis, GO annotation, and KEGG enrichment. Molecular docking analyzed component-target interactions, followed by experimental validation of the core component. Finally, the anti-PCV2 effect of the core component was verified through in vitro and in vivo experiments. RESULTS A total of 135 overlapping targets between Folium Isatidis components and PCV2-related disease targets were identified. Key targets, including AKT1 and TNF-α, were implicated in the therapeutic effects of Folium Isatidis against PCV2. Isovitexin was identified to be the core component that directly binds to AKT1 and TNF-α, thereby inhibiting the PI3K/AKT signaling pathway and regulating TNF-α expression and activity to suppress PCV2 replication and alleviate PCV2-induced lung injury. CONCLUSIONS Our study reveals that Isovitexin, the core anti-PCV2 component of Folium Isatidis, exerts its effect by inhibiting the PI3K/AKT pathway and modulating TNF-α, thereby outlining a novel therapeutic strategy for combating PCV2 infection and associated respiratory injuries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Northwest A&F University, Yangling, China.
- College of Veterinary Medicine, Northwest A&F University, Yangling, China; Engineering Research Center of Efficient New Vaccines for Animals, Ministry of Education, Yangling, China; Key Laboratory of Ruminant Disease Pr…
Förderung
- Chinese Universities Scientific Fund
- National Natural Science Foundation of China
- shaanxi sheng kexue jishu ting
- Natural Science Basic Research Program of Shaanxi Province
Zitieren
APA
Zhu, L., Zhang, G., Kang, J., Xu, X., Zhang, H., Pu, Y., Huang, Y., Tong, D., & Du, Q. (2026). Folium Isatidis suppresses PCV2 replication and alleviates PCV2-induced lung injury by modulating the PI3K/AKT signaling pathway and TNF-α activity. International Immunopharmacology, 179, 116641. https://doi.org/10.1016/j.intimp.2026.116641
Vancouver
Zhu L, Zhang G, Kang J, Xu X, Zhang H, Pu Y, et al. Folium Isatidis suppresses PCV2 replication and alleviates PCV2-induced lung injury by modulating the PI3K/AKT signaling pathway and TNF-α activity. International Immunopharmacology. 2026;179:116641. doi:10.1016/j.intimp.2026.116641
BibTeX
@article{Zhu2026,
author = {Zhu, Lei and Zhang, Guan and Kang, Jiasai and Xu, Xinru and Zhang, Haoshu and Pu, Yingying and Huang, Yong and Tong, Dewen and Du, Qian},
title = {Folium Isatidis suppresses PCV2 replication and alleviates PCV2-induced lung injury by modulating the PI3K/AKT signaling pathway and TNF-α activity},
journal = {International Immunopharmacology},
year = {2026},
volume = {179},
pages = {116641},
doi = {10.1016/j.intimp.2026.116641}
}
EUVIMED